Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7745391 Human thrombospondin polypeptide

Patent 7745391 was granted and assigned to COMPUGEN LTD on June, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

June 29, 2010

Patent Application Number

11443428

Date Filed

May 31, 2006

Patent Citations Received

US Patent 12129311 Cyclic peptide combinatorial libraries

0

US Patent 12064407 Endogenous retrovirus-k (ERVK) encodes an alternate envelope protein

0

US Patent 12084722 Methods of determining responsiveness to anti-TNFα therapy in inflammatory bowel disease

0

US Patent 12091662 Compositions for modulating tau expression

0

US Patent 11702466 Fusion protein comprising a blood-brain barrier (BBB)-crossing single domain antibody Fc5, an immunoglobulin Fc fragment and a beta-amyloid binding polypeptide (ABP)

0

US Patent 11744846 Allele specific modulators of P23H rhodopsin

US Patent 11753443 Conjugated hepcidin mimetics

US Patent 11767520 Compositions and methods for treating lung inflammation

...

Patent Primary Examiner

David J. Steadman

Patent abstract

A human thrombospondin 1 protein, polynucleotide encoding the protein, and pharmaceutical composition thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7745391 Human thrombospondin polypeptide

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool